Rating History for Spruce Biosciences, Inc. (SPRB) by Guggenheim
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 6/16/2026 | Debjit Chattopadhyay | New Coverage | Buy (N/A) |
123.00 (N/A) |
49.91 (43.54) |
-12.76% | Details |
 |
|||||||
|
|||||||
